Department of Psychology, University of Oviedo, Oviedo, Spain.
Department of Clinical Psychology and Psychobiology, University of Santiago de Compostela, Santiago de Compostela, Spain.
PLoS One. 2017 Dec 5;12(12):e0188849. doi: 10.1371/journal.pone.0188849. eCollection 2017.
We conducted a systematic literature review and meta-analysis (ID: CRD42016051017) of smoking cessation interventions for patients with current depression. We examined the effectiveness of smoking cessation treatments in improving abstinence rates and depressive symptoms. The following electronic databases were used for potentially eligible studies: PUBMED, PSYCINFO, DIALNET and WEB OF KNOWLEDGE. The search terms used were: smoking cessation, depressive disorder, depression, mood, depressive, depressed, smoking, smokers, nicotine, nicotine dependence, and tobacco cigarette smoking. The methodological quality of included studies was assessed using the Effective Public Health Practice Project Quality assessment tool (EPHPP). Of the 6,584 studies identified, 20 were eligible and included in the review. Trial designs of studies were 16 randomized controlled trials and 4 secondary studies. Studies included three types of intervention: psychological (6/30%), pharmacological (6/30%) or combined (8/40%). Four trials comprised special populations of smokers. Four studies received a strong methodological quality, 7 were scored as moderate and 9 studies received a weak methodological rating. Analyses of effectiveness showed that smoking cessation interventions appear to increase short-term and long-term smoking abstinence in individuals with current depression. Subgroup analyses revealed stronger effects among studies that provided pharmacological treatments than in studies using psychological treatments. However, the evidence is weak due to the small number of studies. Smoking abstinence appears to be associated with an improvement in depressive symptoms. Heterogeneity in protocols in similar types of treatment also prevent firm conclusions being drawn on the effectiveness of any particular treatment model to optimally manage abstinence among depressed smokers. Further research is required to strengthen the evidence base.
我们对有当前抑郁症的患者的戒烟干预进行了系统的文献回顾和荟萃分析(ID:CRD42016051017)。我们研究了戒烟治疗在提高戒烟率和改善抑郁症状方面的效果。我们使用了以下电子数据库来寻找潜在符合条件的研究:PUBMED、PSYCINFO、DIALNET 和 WEB OF KNOWLEDGE。使用的搜索词是:戒烟、抑郁障碍、抑郁、情绪、抑郁、沮丧、吸烟、吸烟者、尼古丁、尼古丁依赖和烟草香烟吸烟。使用有效的公共卫生实践项目质量评估工具(EPHPP)评估纳入研究的方法学质量。在确定的 6584 项研究中,有 20 项符合条件并纳入了综述。研究的试验设计为 16 项随机对照试验和 4 项次级研究。研究包括三种干预类型:心理(6/30%)、药理学(6/30%)或联合(8/40%)。四项试验包括特殊吸烟人群。四项研究获得了强方法学质量评分,7 项为中等,9 项为弱方法学评分。有效性分析表明,戒烟干预似乎可以提高有当前抑郁症的个体的短期和长期戒烟率。亚组分析显示,提供药理学治疗的研究比使用心理治疗的研究效果更强。然而,由于研究数量较少,证据较弱。戒烟似乎与抑郁症状的改善相关。类似治疗类型的方案中的异质性也阻止了对任何特定治疗模型的有效性得出明确的结论,以最佳地管理抑郁吸烟者的戒烟。需要进一步的研究来加强证据基础。